No significant difference was detected in age, time of stent implantation, gender, hypertension (HTN), diabetes mellitus (DM), smoking history, drinking history, BMI, TC, TG, AST, ALT, serum creatinine, HbA1c, LVEF, WBC and HGB between control and ISH or ISS groups. This evidence concerns the gene CYGB and hypertensive disorder.